Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $1.27M in the quarter ending September 30, 2024, a decrease of -60.82%. This brings the company's revenue in the last twelve months to $6.00M, down -63.40% year-over-year. In the year 2023, Aligos Therapeutics had annual revenue of $15.53M with 11.66% growth.

• Revenue (ttm): $6.00M
• Revenue Growth: -63.40%
• P/S Ratio: 39.65
• Revenue / Employee: $90,864
• Employees: 66
• Market Cap: 147.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	15.53M	1.62M	11.66%
Dec 31, 2022	13.91M	9.55M	219.04%
Dec 31, 2021	4.36M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.